Back Login to subscribe 🔔 Set Alert

ALXO ALX Oncology Holdings Inc. Common Stock

15 min delay
Today's News Sentiment
Loading...
Upcoming Earnings
Loading...
ALXO Fundamental Data
Loading...
ALXO Options Chain
Put/Call Ratio
—
—
Expected Move
—
—
Max Pain
—
—
ATM Call Break-even
—
—
ATM Put Break-even
—
—
Loading options…
CALLS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
PUTS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
ALXO Insider Transactions
Loading insider data…
ALXO News
Date Headline Sentiment
ALX Oncology Holdings Q1 Adj. EPS $(0.15) Beats $(0.22) Estimate
56.48%
ALX Oncology Holdings Announces New Data Supporting Phase 1b/2 Clinical Trial For Evoracept In Combination With Jazz Pharmaceutical's Zanidatamab For Patients With Pre-Treated HER2-Positive Metastatic Breast Cancer
91.19%